GROWTH-INHIBITION OF HUMAN GASTROINTESTINAL CANCER XENOGRAFT LINES BYTREATMENT WITH CPT-11 AND VP-16

Citation
S. Nagai et al., GROWTH-INHIBITION OF HUMAN GASTROINTESTINAL CANCER XENOGRAFT LINES BYTREATMENT WITH CPT-11 AND VP-16, Journal of surgical oncology, 54(4), 1993, pp. 211-215
Citations number
17
Categorie Soggetti
Surgery,Oncology
ISSN journal
00224790
Volume
54
Issue
4
Year of publication
1993
Pages
211 - 215
Database
ISI
SICI code
0022-4790(1993)54:4<211:GOHGCX>2.0.ZU;2-5
Abstract
A water-soluble and stable camptothecin derivative, CPT-11, was found to possess a strong antitumor activity against various murine tumors. In the present study, CPT-11 was tested against ten human gastrointest inal cancer xenograft lines carried by nude mice. CPT-11 was very effe ctive against nine xenograft lines, with the exception of one xenograf t. On the other hand, VP-16 was ineffective against all these xenograf t lines. Therefore, CPT-11 is expected to be clinically more effective against gastrointestinal cancer than the topo II targeting agent. (C) 1993 Wiley-Liss, Inc.